Research > Medicine and experimental therapy

Immunology and Immunopathology Group (GRIIP)

The group of the University of Lleida (UdL) and the Institute of Biomedical Research of Lleida (IRBLleida) is currently constituted by two Principal Investigators and their respective research units. Both investigators have a long history as leading researchers in R & D for more than a decade and a half in the field of immunology and autoimmunity. Both researchers are members of the same research group recognized by the Generalitat (SGR) of the UdL and IRBLleida since its inception.

The research objective of the group is the study of the mechanisms of loss of immunological tolerance in autoimmune endocrine diseases, and more specifically in Type 1 Diabetes (T1D), and in the study of tools for the diagnosis and treatment of these diseases. The group also aims to lay the foundations on a future immunotherapy of T1D and other endocrinopathies of autoimmune origin, through participation and collaboration with different research and care groups.

Featured publication

Rodriguez-Fernandez S; Pujol-Autonell I; Brianso F; Perna-Barrull D; Cano-Sarabia M; Garcia-Jimeno S; Villalba A; Sanchez A; Aguilera E; Vazquez F; Verdaguer J; Maspoch D; Vives-Pi M

Phosphatidylserine-liposomes Promote Tolerogenic Features on Dendritic cells in human Type 1 Diabetes by apoptotic Mimicry

Frontiers in Immunology 9 253-253. .

[doi:10.3389/fimmu.2018.00253]

All publications

Contact information

Juan Verdaguer Autonell

Juan Verdaguer Autonell

Concepción Mora Giral

Concepción Mora Giral

973702958

joan.verdaguer(ELIMINAR)@mex.udl.cat

conchi.mora(ELIMINAR)@mex.udl.cat

Biomedicine II / Biomedicina II
2nd floor / 2a planta